Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nadim Ahmed currently holds 420,699 shares of Cullinan Oncology, Inc. (CGEM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nadim Ahmed has been a net seller of CGEM stock. They have purchased $100.3K and sold $168.9K worth of shares.
Nadim Ahmed's most recent insider trade was on Dec 23, 2025, when they sold 9,922 shares at $10.01 per share.
Nadim Ahmed serves as Executive at Cullinan Oncology, Inc. (CGEM). They have executed 35 insider transactions totaling $269.2K over their tenure at the company.
Nadim Ahmed holds the position of Executive at Cullinan Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Nadim Ahmed has shown a selling trading pattern, with $100.3K in total purchases and $168.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Nadim Ahmed was on Mar 1, 2020, when they sold $500.4K worth of BMY shares. This transaction involved 8,473 shares at $59.06 per share.
Nadim Ahmed currently owns 420,699 shares of Cullinan Oncology, Inc. (CGEM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nadim Ahmed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nadim Ahmed has 35 Form 4 filings on record as an insider at Cullinan Oncology, Inc..
Set alerts for Nadim Ahmed and 40,000+ other insiders.